am 251 and am 630
am 251 has been researched along with am 630 in 105 studies
Research
Studies (105)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 32 (30.48) | 29.6817 |
2010's | 65 (61.90) | 24.3611 |
2020's | 8 (7.62) | 2.80 |
Authors
Authors | Studies |
---|---|
Adinolfi, B; Benetti, V; Cascio, MG; Di Marzo, V; Ferrarini, PL; Ligresti, A; Lucchesi, V; Manera, C; Martinelli, A; Masini, E; Nieri, P; Saccomanni, G; Tuccinardi, T | 1 |
Allen, JG; Babij, P; Fotsch, C | 1 |
Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A | 1 |
Chen, X; Darras, FH; Decker, M; Heilmann, J; Nimczick, M; Pemp, D | 1 |
Bánki, L; Deli, MA; Dvorácskó, S; Horváth, G; Kékesi, G; Keresztes, A; Macedonio, G; Mollica, A; Pieretti, S; Stefanucci, A; Tömböly, C; Tuboly, G; Walter, FR; Zádor, F | 1 |
Cabanlong, CV; Crooks, PA; Dachavaram, SS; Penthala, NR; Prather, PL; Shoeib, A; Yang, J; Zhan, CG | 1 |
Deng, H; Ibrahim, MM; Liu, Q; Makriyannis, A; Malan, PT; Mata, HP; Porreca, F; Vanderah, T | 1 |
Bottrill, FE; Ford, WR; Hiley, CR; Ho, WS; White, R | 1 |
Choi, JI; Yoon, MH | 1 |
Johanek, LM; Simone, DA | 1 |
Bianchi, R; Borsani, E; Buffoli, B; Rezzani, R; Ricci, F; Rodella, LF | 1 |
Baker, D; Greig, IR; Idris, AI; Ralston, SH; Ridge, SA; Ross, RA; van 't Hof, RJ | 1 |
Barun, S; Dileköz, E; Ercan, ZS; Sarioglu, Y; Vural, IM | 1 |
Beaulieu, P; De Léan, A; Guindon, J | 1 |
Abesser, M; Ertl, G; Harvey-White, J; Wagner, JA | 1 |
Fowler, CJ; Jacobsson, SO; Nilsson, O | 1 |
de la Cal, C; Elverdin, JC; Fernández-Solari, J; Iribarne, M; McCann, SM; Prestifilippo, JP; Rettori, V; Suburo, AM | 1 |
Baik, SK; Dehpour, AR; Gaskari, SA; Lee, SS; Liu, H; Moezi, L | 1 |
Beaulieu, P; Desroches, J; Guindon, J | 1 |
Bianchi, R; Borsani, E; Labanca, M; Rodella, LF | 1 |
Beaulieu, P; Dani, M; Desroches, J; Guindon, J | 1 |
Hsu, KS; Huang, CC; Liang, YC | 1 |
Beaulieu, P; Dani, M; Guindon, J; Lambert, C | 1 |
Kendall, DA; Ralevic, V; Wilkinson, JD | 1 |
Shimizu, T; Yokotani, K | 1 |
Finn, DP; Kelly, JP; O'Driscoll, M; Roche, M | 1 |
Araújo, JR; Azevedo, I; Gonçalves, P; Martel, F | 1 |
Ballesteros, I; Chancellor, MB; Coyle, CH; de Miguel, F; Hayn, MH; Tyagi, P; Tyagi, S; Yoshimura, N | 1 |
da Fonseca Pacheco, CM; da Fonseca Pacheco, D; de Castro Perez, A; de Francischi, JN; Duarte, ID; Klein, A | 1 |
Idris, AI; Landao-Bassonga, E; Ralston, SH; Sophocleous, A; van't Hof, RJ | 1 |
Araújo, JR; Gonçalves, P; Martel, F | 1 |
Chen, L; Li, F; Li, M; Li, YH; Pan, HL; Qiu, Y; Shi, J; Wang, L; Zhang, J | 1 |
Challapalli, SC; Smith, PJ; Zhang, F | 1 |
Grider, JR; Kuemmerle, JF; Li, Y; Mahavadi, S; Martin, BR; Murthy, KS; Qiao, LY | 1 |
de Francischi, JN; Duarte, ID; Klein, A; Pacheco, CM; Pacheco, Dda F; Perez, AC; Reis, GM | 1 |
Ding, Q; Dong, H; Ma, R; Su, B; Xiong, L; Zhang, X | 1 |
Lewis, AW; Neuendorff, DA; Randel, RD; Weems, CW; Weems, YS | 1 |
Touriño, C; Valverde, O; Zimmer, A | 1 |
Biwasa, KK; Hashiguchi, T; Kadomatsu, H; Kawahara, K; Kozono, S; Maruyama, I; Matsuyama, T; Nakajima, Y; Noguchi, K; Tancharoen, S; Yonamine, Y; Yoshimoto, T | 1 |
Elverdin, JC; Fernandez-Solari, J; Ossola, CA; Prestifilippo, JP; Rettori, V | 1 |
Barrett, F; Keown, OP; Leslie, SJ; Macrury, SM; Megson, IL; Neilson, I; Wainwright, CL; Winterburn, TJ | 1 |
Chambers, MG; Jassal, K; Johnson, MP; McDougall, JJ; Oskins, JL; Schuelert, N | 1 |
Grinfeld, E; Hryciw, DH; Jenkin, KA; McAinch, AJ | 1 |
Azcoitia, I; Bellini, MJ; Bermudez-Silva, FJ; Garcia-Segura, LM; López Rodríguez, AB; Mateos Vicente, B; Rodriguez de Fonseca, F; Rodriguez-Rodriguez, N; Romero-Zerbo, SY; Viveros, MP | 1 |
Abalo, R; González, C; Herradón, E; Leza, JC; López-Miranda, V; Martín, MI; Pérez-Nievas, BG; Vera, G | 1 |
Carlson, OD; Doyle, ME; Egan, JM; Kim, HS; Kim, W; Kulkarni, RN; Lao, Q; Lee, EK; Liu, Z; Martin, B; Maudsley, S; Moaddel, R; Napora, JK; Shin, YK; Thomas, S; Wang, Y | 1 |
Akopian, AN; Hargreaves, KM; Patil, M; Patwardhan, A; Salas, MM | 1 |
Feng, JY; Feng, YJ; Li, K; Li, YN; Li, YY; Lin, XH; Storr, M; Yu, LY; Yuece, B | 1 |
Alhamoruni, A; Larvin, M; O'Sullivan, SE; Wright, KL | 1 |
Funada, M; Tomiyama, K | 1 |
Fang, Q; Han, ZL; He, N; Li, N; Wang, R; Wang, ZL | 1 |
Hervera, A; Leánez, S; Martín-Campos, JM; Negrete, R; Pol, O | 1 |
Li, DP; Li, Q; Ma, HJ; Shi, M; Song, SL; Zhang, Y | 1 |
Keresztes, A; Largent-Milnes, TM; Ren, J; Roeske, WR; Tumati, S; Vanderah, TW; Varga, EV | 1 |
Bagües Arias, A; Martín Fontelles, MI; Sánchez Robles, EM | 1 |
Baranowska-Kuczko, M; Kozłowska, H; MacLean, MR; Malinowska, B | 1 |
De Laurentiis, A; Elverdin, JC; Rettori, E; Rettori, V; Zorrilla Zubilete, M | 1 |
Deng, L; Guindon, J; Hohmann, AG; Makriyannis, A; Thakur, GA; Vemuri, VK; White, FA | 1 |
Duarte, ID; Pacheco, Dda F; Romero, TR | 1 |
Araújo, JC; Brito, GA; Cavalcante, AL; Gondim, DV; Havt, A; Lima Vale, M; Quetz, Jda S; Ribeiro, Rde A | 1 |
Li, Q; Wang, SY; Wei, Y; Yang, J; Zhang, J; Zhang, Y; Zhou, JJ | 1 |
Cui, N; Du, Y; Li, Q; Ma, H; Zhang, Y | 1 |
Aguiar, DC; Almeida-Santos, AF; Gobira, PH; Guimaraes, FS; Moreira, FA; Rosa, LC | 1 |
Ferraz, JG; Flannigan, KL; McKnight, W; Tuitt, D; Wallace, JL; Wang, L | 1 |
Finn, DP; Garcia-Segura, LM; Jafarian-Tehrani, M; Lopez-Rodriguez, AB; Marchand-Leroux, C; Siopi, E; Viveros, MP | 1 |
Aguiar, DC; Cruz, JS; de Paula, AM; Di Marzo, V; Duarte, ID; Galdino, G; Parrella, C; Perez, AC; Piscitelli, F; Romero, TR; Silva, JF | 1 |
Hinz, B; Peters, K; Ramer, R; Salamon, A; Schmuhl, E | 1 |
Al Kury, LT; Ali, RM; Galadari, S; Howarth, FC; Oz, M; Shuba, YM; Voitychuk, OI; Yang, KH | 1 |
Bradshaw, HB; Cygankiewicz, A; Fichna, J; Kordek, R; Krajewska, WM; Leishman, E; Małecka-Panas, E; Mokrowiecka, A; Sałaga, M; Sobczak, M; Storr, M; Zakrzewski, PK; Zatorski, H | 1 |
Keller, A; Raver, SM | 1 |
Krustev, E; McDougall, JJ; Reid, A | 1 |
Calik, MW; Carley, DW | 2 |
Bagüés, A; Martín, MI; Sánchez-Robles, EM | 1 |
Chen, CY; Chi, CW; Li, CP; Ting, CH | 1 |
Biala, G; Kruk-Slomka, M; Michalak, A | 1 |
Gao, F; Ji, M; Li, F; Li, Q; Miao, Y; Qian, WJ; Sun, XH; Wang, SY; Wang, Z; Yang, W | 1 |
Biala, G; Boguszewska-Czubara, A; Budzynska, B; Kruk-Slomka, M; Slomka, T | 1 |
Bakali, E; Elliott, RA; Lambert, DG; Mason, R; Mbaki, Y; Tincello, DG | 1 |
Beierschmitt, A; Bouchard, JF; Bouskila, J; Casanova, C; Harrar, V; Javadi, P; Palmour, R; Ptito, M | 1 |
Adams, MJ; Geraghty, DP; Kunde, DA; Omari, SA | 1 |
Chancellor, MB; Hikita, K; Honda, M; Kawamoto, B; Muraoka, K; Saito, M; Shimizu, S; Takenaka, A; Yoshimura, N | 1 |
Engidawork, E; Geresu, B; Onaivi, E | 1 |
Baggio, CH; Bertoglio, LJ; Cristina de Carvalho, M; Cunha, JM; da Silva, LM; da Silva-Santos, JE; de Morais, H; de Souza, CP; Ferreira, DM; Vanvossen, AC; Zanoveli, JM | 1 |
Hinz, B; Ivanov, I; Scholl, A | 1 |
Almeida, RT; de Souza, GG; Duarte, ID; Perez, AC; Romero, MG; Romero, TR | 1 |
Amini-Khoei, H; Amiri, S; Dehpour, AR; Ghesmati, M; Haj-Mirzaian, A; Shafaroodi, H; Zahir, M | 1 |
Calixto, JB; Costa, R; Freitas, CS; Manjavachi, MN; Matias, DO; Passos, GF; Segat, GC | 1 |
Fang, B; Jing, N; Ma, H; Wang, ZL | 1 |
Fichna, J; Misicka, A; Sacharczuk, M; Wasilewski, A | 1 |
Anli, G; Bilir, KA; Gunduz, O; Ozkan, E; Ulugol, A | 1 |
Fang, Q; Shi, X; Wang, P; Xu, B; Zhang, M; Zhang, Q; Zhang, R; Zhang, T; Zhao, W; Zheng, T | 1 |
Hohmann, AG; Iyer, V; Makriyannis, A; Saberi, SA; Slivicki, RA; Vemuri, VK | 1 |
Kossakowski, R; Malinowska, B; Pędzińska-Betiuk, A; Weresa, J | 1 |
Aguiar, DC; Bastos, JR; Coimbra, CC; Costa, RB; Hott, SC; Mansur, FS; Moreira, FA; Resstel, LB; Viana, TG | 1 |
Duarte, IDG; Pacheco, DDF; Romero, TRL | 1 |
Bi, GH; Galaj, E; He, Y; Xi, ZX | 1 |
Ali, DW; Allison, WT; Amin, MR; Kanyo, R; Sufian, MS | 1 |
Arslan, R; Bektas, N; Dikmen, DY; Okcay, Y | 1 |
Babaie, J; Ghanbari, MM; Joneidi, M; Kiani, B; Sayyah, M | 1 |
Liu, S; Liu, X; Lu, Y; Wu, Y; Xie, Y; Yang, R; Zhou, D; Zhou, Y | 1 |
Chung, YC; Jin, BK; Wi, R | 1 |
Escayg, A; Gado, F; Manera, C; Shapiro, L | 1 |
Ghanbari, MM; Loron, AG; Sayyah, M | 1 |
Hara, K; Haranishi, Y; Terada, T | 1 |
Reviews
1 review(s) available for am 251 and am 630
Article | Year |
---|---|
Emerging targets in osteoporosis disease modification.
Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis | 2010 |
Other Studies
104 other study(ies) available for am 251 and am 630
Article | Year |
---|---|
Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Humans; Jurkat Cells; Models, Molecular; Molecular Structure; Naphthyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2009 |
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism | 2011 |
Synthesis and biological evaluation of bivalent cannabinoid receptor ligands based on hCB₂R selective benzimidazoles reveal unexpected intrinsic properties.
Topics: Benzimidazoles; Drug Design; Humans; Kinetics; Ligands; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2014 |
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Enkephalins; Indoles; Mice; Molecular Structure; Naphthalenes; Oxycodone; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, mu; Structure-Activity Relationship | 2019 |
7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
Topics: Aza Compounds; Dose-Response Relationship, Drug; Humans; Indoles; Ligands; Molecular Structure; Quinuclidines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2020 |
CB2 cannabinoid receptor-mediated peripheral antinociception.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Indoles; Male; Morpholines; Naphthalenes; Pain Measurement; Peripheral Nervous System; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug | 2001 |
Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
Topics: Amides; Animals; Arachidonic Acids; Capsaicin; Coronary Vessels; Dose-Response Relationship, Drug; Endocannabinoids; Endothelium, Vascular; Ethanolamines; Gap Junctions; Glycyrrhetinic Acid; In Vitro Techniques; Indoles; Indomethacin; Male; Palmitic Acids; Peptides; Piperidines; Polyunsaturated Alkamides; Potassium Channel Blockers; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Serotonin; Tetraethylammonium; Vasodilation | 2001 |
Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test.
Topics: Adrenergic alpha-Agonists; Analgesics; Animals; Antineoplastic Agents; Behavior, Animal; Benzoxazines; Cannabinoids; Cholinesterase Inhibitors; Clonidine; Dose-Response Relationship, Drug; Drug Interactions; Formaldehyde; Indoles; Injections, Spinal; Male; Morpholines; Naphthalenes; Neostigmine; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug | 2003 |
Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Topics: Animals; Benzoxazines; Burns; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Disease Models, Animal; Hot Temperature; Hyperalgesia; Indoles; Male; Morpholines; Naphthalenes; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Nociceptors; Pain; Pain Measurement; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Reflex; Skin | 2004 |
AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
Topics: Animals; Arachidonic Acids; Capsaicin; Constriction; Dose-Response Relationship, Drug; Endocannabinoids; Immunohistochemistry; Indoles; Male; Physical Stimulation; Piperidines; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord | 2005 |
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.
Topics: Animals; Apoptosis; Bone and Bones; Bone Density; Bone Resorption; Camphanes; Carrier Proteins; Cells, Cultured; Female; Indoles; Ligands; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoclasts; Ovariectomy; Piperidines; Pyrazoles; Rabbits; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2005 |
Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips.
Topics: Animals; Arachidonic Acids; Benzoxazines; Calcium Channel Blockers; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Endocannabinoids; In Vitro Techniques; Indoles; Male; Morpholines; Muscle Contraction; Muscle, Smooth; Naloxone; Naphthalenes; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rabbits; Receptors, Cannabinoid; Sympathetic Nervous System; Vas Deferens | 2005 |
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain.
Topics: Acute Disease; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Area Under Curve; Cannabinoid Receptor Modulators; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Endocannabinoids; Ibuprofen; Indoles; Inflammation; Male; Pain; Pain Measurement; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Random Allocation; Rats | 2006 |
2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
Topics: Animals; Arachidonic Acids; Blood Pressure; Cannabinoid Receptor Modulators; Coronary Vessels; Endocannabinoids; Glycerides; Heart; Heart Rate; Indoles; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Regional Blood Flow | 2006 |
The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
Topics: Analysis of Variance; Arachidonic Acids; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cell Line; Cell Movement; Chemotaxis; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Endothelial Cells; Flow Cytometry; Humans; Indoles; Interleukin-8; L-Lactate Dehydrogenase; Morpholines; Naphthalenes; Neutrophils; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Thapsigargin; Tumor Necrosis Factor-alpha | 2006 |
Inhibition of salivary secretion by activation of cannabinoid receptors.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Colforsin; Cyclic AMP; Endocannabinoids; Immunohistochemistry; Indoles; Male; Methacholine Chloride; Norepinephrine; Parasympathomimetics; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Saliva; Submandibular Gland; Sympathomimetics | 2006 |
Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
Topics: Animals; Arachidonic Acids; Bile Ducts; Blood Flow Velocity; Blood Pressure; Blotting, Western; Capsaicin; Cardiac Output; Disease Models, Animal; Endocannabinoids; Hyperemia; Indoles; Liver Circulation; Liver Cirrhosis, Biliary; Male; Mesenteric Artery, Superior; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Splanchnic Circulation; Time Factors; TRPV Cation Channels; Vascular Resistance; Vasodilation; Vasodilator Agents | 2006 |
The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.
Topics: Analgesics, Non-Narcotic; Animals; Arachidonic Acids; Biphenyl Compounds; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Glycerides; Indoles; Male; Monoacylglycerol Lipases; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2007 |
AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
Topics: Animals; Arachidonic Acids; Capsaicin; Endocannabinoids; Immunohistochemistry; Indoles; Inflammation; Male; Pain; Pain Measurement; Piperidines; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spinal Cord; TRPV Cation Channels | 2007 |
Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Hyperalgesia; Indoles; Male; Morpholines; Naphthalenes; Pain; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sciatic Nerve; Sciatic Neuropathy | 2007 |
The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
Topics: Analgesics; Analysis of Variance; Animals; Benzoxazines; Cannabinoids; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Hyperalgesia; Hyperesthesia; Indoles; Male; Morpholines; Naphthalenes; Pain Measurement; Pain Threshold; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB1; Time Factors; Trigeminal Nerve Diseases | 2007 |
The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Arachidonic Acids; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Hindlimb; Hot Temperature; Hyperalgesia; Indoles; Male; Neuralgia; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Sciatic Nerve | 2007 |
Delta 9-tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Dose-Response Relationship, Drug; Dronabinol; Electric Stimulation; Indoles; Male; Mesenteric Arteries; Methoxamine; Neurons, Afferent; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Ruthenium Red; Time Factors; Vasodilation | 2007 |
Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats.
Topics: Adrenal Medulla; Animals; Arachidonic Acids; Arginine Vasopressin; Benzoxazines; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Catecholamines; Cyclohexanones; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Epinephrine; Glycerides; Indoles; Injections, Intraventricular; Male; Morpholines; Naphthalenes; Norepinephrine; Organophosphonates; Piperidines; Pyrazoles; Rats; Rats, Wistar | 2008 |
Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats.
Topics: Anilides; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Cinnamates; Cytokines; Drug Synergism; Indoles; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2008 |
Lack of a significant effect of cannabinoids upon the uptake of 2-deoxy-D-glucose by Caco-2 cells.
Topics: Arachidonic Acids; Caco-2 Cells; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Cyclohexanols; Deoxyglucose; Dronabinol; Endocannabinoids; Humans; Indoles; Intestinal Absorption; Piperidines; Polyunsaturated Alkamides; Pyrazoles | 2008 |
Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder.
Topics: Animals; Calcitonin Gene-Related Peptide; Dronabinol; Female; Indoles; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Tissue Culture Techniques; Urinary Bladder | 2008 |
The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
Topics: Amidohydrolases; Analgesics, Opioid; Animals; Arachidonic Acids; Benzamides; Benzomorphans; Cannabinoid Receptor Modulators; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hyperalgesia; Indoles; Male; Morphine; Organophosphonates; Pain; Pain Measurement; Piperazines; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2008 |
Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.
Topics: Animals; Bone and Bones; Bone Density; Bone Marrow Cells; Bone Resorption; Cannabinoids; Cells, Cultured; Coculture Techniques; Drug Evaluation, Preclinical; Drug Inverse Agonism; Female; Indoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Osteoclasts; Ovariectomy; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB2 | 2008 |
Effect of cannabinoids upon the uptake of folic acid by BeWo cells.
Topics: Arachidonic Acids; Carrier Proteins; Cell Culture Techniques; Cell Line, Tumor; Cyclohexanols; Dronabinol; Drug Administration Schedule; Endocannabinoids; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hydrogen-Ion Concentration; Indoles; Membrane Transport Proteins; Piperidines; Placenta; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cell Surface | 2009 |
Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats.
Topics: Animals; Arachidonic Acids; Chromatography, High Pressure Liquid; Electroacupuncture; Endocannabinoids; Freund's Adjuvant; Hindlimb; Hot Temperature; Hyperalgesia; Indoles; Male; Pain; Pain Management; Physical Stimulation; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Skin | 2009 |
Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.
Topics: Animals; Calcium; Capsaicin; Diabetic Neuropathies; Dose-Response Relationship, Drug; Dronabinol; Glucose; Hyperglycemia; Indoles; Nerve Growth Factor; Neurites; Neurogenesis; Neurons; Neuroprotective Agents; PC12 Cells; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Sensory System Agents | 2009 |
Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids.
Topics: Animals; Arachidonic Acids; Calcitonin Gene-Related Peptide; Cannabinoid Receptor Modulators; Colon; Dose-Response Relationship, Drug; Endocannabinoids; Guinea Pigs; In Vitro Techniques; Indoles; Motor Neurons; Neural Inhibition; Peristalsis; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex; Sensory Receptor Cells; Substance P; Vasoactive Intestinal Peptide | 2009 |
Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor.
Topics: Analgesics, Opioid; Animals; Indoles; Male; Mice; Morphine; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2009 |
Cannabinoid 1 receptor mediation of spinal cord ischemic tolerance induced by limb remote ischemia preconditioning in rats.
Topics: Animals; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Indoles; Ischemia; Ischemic Preconditioning; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reperfusion Injury; Spinal Cord | 2009 |
Endocannabinoid 1 and 2 (CB(1); CB(2)) receptor agonists affect negatively cow luteal function in vitro.
Topics: Adenine; Adenosine; Animals; Arachidonic Acids; Cattle; Corpus Luteum; Dinoprost; Dinoprostone; Female; In Vitro Techniques; Indoles; Organophosphonates; Piperidines; Pregnancy; Progesterone; Pyrazoles; Pyrrolidines; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2009 |
THC Prevents MDMA Neurotoxicity in Mice.
Topics: Animals; Astrocytes; Body Temperature; Dronabinol; Fever; Hallucinogens; Indoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Piperidines; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Temperature | 2010 |
Involvement of the endocannabinoid system in periodontal healing.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cell Proliferation; Endocannabinoids; Fibroblasts; Gingival Crevicular Fluid; Glycerides; Humans; Indoles; p38 Mitogen-Activated Protein Kinases; Periodontium; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Wound Healing | 2010 |
Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion.
Topics: Amidohydrolases; Animals; Arachidonic Acid; Arachidonic Acids; Cannabinoid Receptor Modulators; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Endocannabinoids; Etanercept; Immunoglobulin G; Immunologic Factors; In Vitro Techniques; Indoles; Lipopolysaccharides; Male; Methacholine Chloride; Muscarinic Agonists; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Saliva; Salivation; Secretory Rate; Submandibular Gland; Tumor Necrosis Factor-alpha | 2010 |
2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors.
Topics: Adolescent; Adult; Aged; Arachidonic Acids; Aspirin; Blood Platelets; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Coronary Artery Disease; Endocannabinoids; Glycerides; Humans; Indoles; Male; Middle Aged; Piperidines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazoles; Young Adult | 2010 |
Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis.
Topics: Action Potentials; Afferent Pathways; Age Factors; Animals; Arthralgia; Benzamides; Carbamates; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; Indoles; Iodoacetic Acid; Male; Nociceptors; Osteoarthritis; Piperidines; Pyrazoles; Rats; Rats, Wistar; Time Factors; Weight-Bearing | 2011 |
Role for cannabinoid receptors in human proximal tubular hypertrophy.
Topics: Animals; Arachidonic Acids; Cell Enlargement; Cell Line; Endocannabinoids; Humans; Indoles; Kidney Tubules, Proximal; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; TRPV Cation Channels | 2010 |
Estradiol decreases cortical reactive astrogliosis after brain injury by a mechanism involving cannabinoid receptors.
Topics: Animals; Brain Injuries; Cannabinoid Receptor Modulators; Cannabinoids; Cerebral Cortex; Estradiol; Glial Fibrillary Acidic Protein; Gliosis; Immunohistochemistry; Indoles; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; RNA, Messenger; Stereotaxic Techniques; Tissue Fixation; Vimentin; Wounds, Stab | 2011 |
Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.
Topics: Animals; Benzoxazines; Cannabinoids; Cardiotonic Agents; Coronary Vessels; Diabetes Mellitus, Type 2; Heart; Heart Rate; Indoles; Male; Morpholines; Myocardial Ischemia; Myocardial Reperfusion Injury; Naphthalenes; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Piperidines; Pyrazoles; Rats; Rats, Zucker; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2011 |
Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells.
Topics: Animals; Blotting, Western; Cell Proliferation; Cells, Cultured; Female; Glucose; GTP-Binding Protein alpha Subunit, Gi2; Humans; Immunoprecipitation; In Vitro Techniques; Indoles; Insulin-Secreting Cells; Male; Mice; Mice, Mutant Strains; Mice, Obese; Piperidines; Potassium Chloride; Protein Binding; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Insulin; Signal Transduction | 2011 |
Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons.
Topics: Animals; Cannabinoid Receptor Antagonists; CHO Cells; Cricetinae; Cricetulus; Indoles; Mice; Mice, 129 Strain; Mice, Knockout; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Sensory Receptor Cells; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2011 |
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents.
Topics: Animals; Cannabidiol; Electromyography; Gastrointestinal Motility; Gastrointestinal Transit; Indoles; Inflammation; Interleukin-6; Intestines; Ligands; Lipopolysaccharides; Membrane Potentials; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Piperidines; Pyrazoles; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha | 2011 |
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability.
Topics: Amidohydrolases; Benzamides; Benzodioxoles; Caco-2 Cells; Cannabinoids; Carbamates; Cell Survival; Enzyme Inhibitors; Humans; Indoles; Inflammation; Interferon-gamma; Intestinal Mucosa; Monoacylglycerol Lipases; Permeability; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Tumor Necrosis Factor-alpha | 2012 |
Cytotoxicity of synthetic cannabinoids found in "Spice" products: the role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line.
Topics: Apoptosis; Cannabinoids; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Cyclohexanols; Cysteine Proteinase Inhibitors; Drug Interactions; Humans; Indoles; Microscopy, Fluorescence; Oligopeptides; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2011 |
Effects of neuropeptide FF system on CB₁ and CB₂ receptors mediated antinociception in mice.
Topics: Analgesia; Analgesics; Animals; Benzoxazines; Indoles; Male; Mice; Morpholines; Naloxone; Naphthalenes; Oligopeptides; Pain; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2012 |
The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids.
Topics: Analgesics; Analgesics, Opioid; Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cyclic GMP; Glyburide; Indoles; KATP Channels; Mice; Mice, Knockout; Naloxone; Nitric Oxide; Nitric Oxide Synthase Type I; Pain; Piperidines; Pyrazoles; Quaternary Ammonium Compounds; Receptors, Cannabinoid; Signal Transduction; Thionucleotides | 2011 |
Effects of anandamide on potassium channels in rat ventricular myocytes: a suppression of I(to) and augmentation of K(ATP) channels.
Topics: Animals; Anti-Arrhythmia Agents; Arachidonic Acids; Arrhythmias, Cardiac; Cardiac Electrophysiology; Dose-Response Relationship, Drug; Endocannabinoids; Heart Ventricles; Indoles; KATP Channels; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2012 |
Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist.
Topics: Analgesics; Analgesics, Opioid; Animals; Cannabinoids; Hyperalgesia; Indoles; Inflammation; Interleukin-1beta; Male; Morphine; Neuroglia; Pain; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Spinal Cord; Tumor Necrosis Factor-alpha | 2012 |
Cannabinoids and muscular pain. Effectiveness of the local administration in rat.
Topics: Animals; Arachidonic Acids; Behavior, Animal; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Indoles; Male; Morpholines; Motor Activity; Musculoskeletal Pain; Naphthalenes; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar; Treatment Outcome | 2012 |
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amidohydrolases; Animals; Anisoles; Apamin; Arachidonic Acids; Benzamides; Benzyl Compounds; Cannabinoid Receptor Antagonists; Capsaicin; Carbamates; Charybdotoxin; Cyclohexanes; Endocannabinoids; Endothelium, Vascular; Imidazoles; Indoles; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Piperidines; Polyunsaturated Alkamides; Potassium Channel Blockers; Potassium Chloride; Prostaglandin-Endoperoxide Synthases; Pulmonary Artery; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Epoprostenol; Tetraethylammonium; TRPV Cation Channels; Vasodilation | 2012 |
Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Arachidonic Acids; Body Weight; Cannabinoid Receptor Agonists; Corticosterone; Disease Models, Animal; Endocannabinoids; Enzyme-Linked Immunosorbent Assay; Exploratory Behavior; Indoles; Interleukin-1beta; Male; Nitric Oxide Synthase; Periodontitis; Piperidines; Polyunsaturated Alkamides; Prostaglandins E; Pyrazoles; Rats; Rats, Wistar; Statistics, Nonparametric; Stress, Psychological; Tumor Necrosis Factor-alpha | 2012 |
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.
Topics: Animals; Benzylamines; Chromones; Cisplatin; Cryopyrin-Associated Periodic Syndromes; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hyperalgesia; Indoles; Male; Paclitaxel; Peripheral Nervous System Diseases; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptors, CXCR4; Signal Transduction; Time Factors; Treatment Outcome | 2012 |
Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Topics: Amides; Analysis of Variance; Animals; Arachidonic Acids; Calcium Channel Blockers; Cannabinoid Receptor Agonists; Chloride Channels; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Hyperalgesia; Indoles; Male; Niflumic Acid; Palmitic Acids; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2013 |
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint.
Topics: Acupuncture Analgesia; Animals; Arthritis, Experimental; Behavior, Animal; Down-Regulation; Electroacupuncture; Indoles; Male; Nerve Tissue Proteins; Nociception; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Temporomandibular Joint; Trigeminal Nucleus, Spinal; Up-Regulation; Zymosan | 2012 |
Inhibitory effects of endocannabinoid on the action potential of pacemaker cells in sinoatrial nodes of rabbits.
Topics: Action Potentials; Animals; Arachidonic Acids; Cannabinoid Receptor Antagonists; Endocannabinoids; Indoles; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Piperidines; Polyunsaturated Alkamides; Potassium Channel Blockers; Pyrazoles; Rabbits; Sinoatrial Node | 2013 |
Anandamide reduces intracellular Ca2+ concentration through suppression of Na+/Ca2+ exchanger current in rat cardiac myocytes.
Topics: Aniline Compounds; Animals; Arachidonic Acids; Calcium; Cannabinoids; Cell Separation; Endocannabinoids; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Ventricles; Indoles; Intracellular Space; Ion Channel Gating; Male; Myocardial Ischemia; Myocytes, Cardiac; Pertussis Toxin; Phenyl Ethers; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Sodium-Calcium Exchanger; Solutions | 2013 |
Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray.
Topics: Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Biphenyl Compounds; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Indoles; Male; Maze Learning; Periaqueductal Gray; Piperidines; Pyrazoles; Rats; Rats, Wistar | 2013 |
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cannabis; Colitis; Gastrointestinal Tract; Hydrogen Sulfide; Indoles; Male; Naproxen; Piperidines; Plant Extracts; Protective Agents; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stomach Ulcer; Visceral Pain | 2013 |
CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice.
Topics: Animals; Axons; Brain; Brain Edema; Brain Injuries; Cannabinoid Receptor Antagonists; Indoles; Male; Mice; Microglia; Minocycline; Motor Activity; Neuroprotective Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2015 |
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats.
Topics: Analgesia; Animals; Arachidonic Acids; Benzodioxoles; Brain; Cannabinoid Receptor Modulators; Endocannabinoids; Indoles; Male; Organophosphonates; Pain Measurement; Physical Conditioning, Animal; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2014 |
Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Topics: Cannabidiol; Cannabinoids; Cell Differentiation; Cell Movement; Cells, Cultured; Cyclohexanes; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Indoles; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoblasts; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB2; Resorcinols | 2014 |
Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes.
Topics: Action Potentials; Animals; Arachidonic Acids; Caffeine; Calcium; Calcium Signaling; Endocannabinoids; Fura-2; Heart Ventricles; In Vitro Techniques; Indoles; Male; Myocardial Contraction; Myocytes, Cardiac; Pertussis Toxin; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sarcoplasmic Reticulum; Transport Vesicles | 2014 |
Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).
Topics: Amidohydrolases; Animals; Cannabinoids; Colitis, Ulcerative; Disease Models, Animal; Dose-Response Relationship, Drug; Indoles; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Piperidines; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Treatment Outcome | 2014 |
Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms.
Topics: Animals; Benzoxazines; Cannabinoid Receptor Modulators; Dronabinol; Indoles; Male; Mice; Morpholines; Naphthalenes; Piperidines; Prefrontal Cortex; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Somatosensory Cortex; Tissue Culture Techniques | 2014 |
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints.
Topics: Acute Disease; Amidohydrolases; Animals; Arthralgia; Benzamides; Carbamates; Carrageenan; Endocannabinoids; Hindlimb; Hyperalgesia; Indoles; Inflammation; Kaolin; Knee Joint; Male; Mice, Inbred C57BL; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Synovitis; Weight-Bearing | 2014 |
Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
Topics: Animals; Cannabinoid Receptor Agonists; Dronabinol; Electromyography; Femoral Vein; Indoles; Male; Nodose Ganglion; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Serotonin; Sleep Apnea, Obstructive; Treatment Outcome | 2014 |
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
Topics: Analgesics; Animals; Cannabinoid Receptor Agonists; Dronabinol; Indoles; Injections, Intramuscular; Injections, Intraperitoneal; Male; Masseter Muscle; Muscle, Skeletal; Myalgia; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid | 2014 |
Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats.
Topics: Animals; Eating; Endocannabinoids; Fasting; Ghrelin; Hyperphagia; Indoles; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2015 |
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system.
Topics: Animals; Antidepressive Agents; Cannabinoids; Depressive Disorder; Disease Models, Animal; Indoles; Ligands; Male; Mice; Motor Activity; Nicotine; Oleic Acids; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Scopolamine; Swimming | 2015 |
Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
Topics: Animals; Arachidonic Acids; Benzoxazines; Calcium; Calcium Channels; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cells, Cultured; Dose-Response Relationship, Drug; Endocannabinoids; Ependymoglial Cells; Glycerides; Indoles; Male; Membrane Potentials; Morpholines; Naphthalenes; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2016 |
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands.
Topics: Animals; Avoidance Learning; Behavior, Animal; Benzoxazines; Biomarkers; Brain; Cannabinoids; Indoles; Male; Malondialdehyde; Memory; Mice; Morpholines; Naphthalenes; Oxidative Stress; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2016 |
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats.
Topics: Acetic Acid; Administration, Intravesical; Animals; Cannabinoid Receptor Agonists; Cyclohexanols; Disease Models, Animal; Female; Indoles; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urination; Urodynamics | 2016 |
Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys.
Topics: Animals; Chlorocebus aethiops; Electroretinography; Ependymoglial Cells; Indoles; Membrane Potentials; Photic Stimulation; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Retina; Retinal Neurons | 2016 |
Capsaicin-Induced Death of Human Haematological Malignant Cell Lines Is Independent of TRPV1 Activation.
Topics: Cannabinoid Receptor Antagonists; Capsaicin; Cell Death; Cell Line, Tumor; Hematologic Neoplasms; Humans; Indoles; Oxazines; Piperidines; Pyrazoles; TRPV Cation Channels; Xanthenes | 2016 |
Anandamide transporter-mediated regulation of the micturition reflex in urethane-anesthetized rats.
Topics: Administration, Intravenous; Anesthetics, Intravenous; Animals; Arachidonic Acids; Endocannabinoids; Female; Indoles; Membrane Transport Modulators; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex; Urethane; Urination; Urodynamics | 2016 |
Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice.
Topics: Animals; Anxiety; Behavior, Animal; Benzoxazines; Cannabinoid Receptor Agonists; Catha; Endocannabinoids; Indoles; Locomotion; Male; Memory, Short-Term; Mice; Morpholines; Naphthalenes; Piperidines; Plant Extracts; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2016 |
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors.
Topics: Animals; Arachidonic Acids; Behavior, Animal; Brain Chemistry; Calcium Channel Blockers; Depression; Diabetes Mellitus, Experimental; Endocannabinoids; Indoles; Male; Norepinephrine; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Serotonin; Swimming | 2016 |
Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
Topics: Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Capsaicin; Cells, Cultured; Ceramides; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Monocytes; Morpholines; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Partial Thromboplastin Time; Phosphorylation; Piperidines; Pyrazoles; RNA, Messenger; Signal Transduction; Sphingomyelin Phosphodiesterase; Thromboplastin; TRPV Cation Channels | 2016 |
Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats.
Topics: Acupuncture Points; Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Electroacupuncture; Endocannabinoids; Facial Pain; Indoles; Male; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Wistar | 2016 |
Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model of social isolation stress.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Depression; Disease Models, Animal; Indoles; Male; Mice; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Social Isolation; Stress, Psychological | 2017 |
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Cannabinoid Receptor Modulators; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Indoles; Male; Neuralgia; Paclitaxel; Pain Threshold; Peripheral Nervous System Diseases; Piperidines; Polycyclic Sesquiterpenes; Pyrazoles; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sesquiterpenes; Spinal Cord | 2017 |
Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dronabinol; Electroencephalography; Electromyography; Indoles; Male; Piperidines; Polysomnography; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Respiration; Sleep; Sleep Apnea, Central; Sleep, REM; Vagus Nerve | 2017 |
Remote Ischemia Preconditioning Attenuates Blood-Spinal Cord Barrier Breakdown in Rats Undergoing Spinal Cord Ischemia Reperfusion Injury: Associated with Activation and Upregulation of CB1 and CB2 Receptors.
Topics: Animals; Disease Models, Animal; Down-Regulation; Femoral Artery; Indoles; Ischemic Preconditioning; Male; Permeability; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reperfusion Injury; Spinal Cord; Up-Regulation | 2017 |
Modulation of the endocannabinoid system by the fatty acid amide hydrolase, monoacylglycerol and diacylglycerol lipase inhibitors as an attractive target for secretory diarrhoea therapy.
Topics: Amidohydrolases; Animals; Benzodioxoles; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cyclohexanones; Diarrhea; Endocannabinoids; Enzyme Inhibitors; Indoles; Lipoprotein Lipase; Male; Mice; Monoglycerides; Piperidines; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2017 |
Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
Topics: Animals; Benzoxazines; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Indoles; Male; Mice; Mice, Inbred BALB C; Morpholines; Naphthalenes; Piperidines; Pruritus; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Serotonin; Spinal Cord | 2018 |
Antinociceptive effects of the endogenous cannabinoid peptide agonist VD-hemopressin(β) in mice.
Topics: Acetic Acid; Analgesics; Animals; Area Under Curve; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Indoles; Male; Mice; Mice, Inbred Strains; Oligopeptides; Pain; Pain Measurement; Piperidines; Pyrazoles; Rotarod Performance Test; Spinal Cord | 2018 |
Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
Topics: Amidohydrolases; Analgesics, Opioid; Animals; Antineoplastic Agents; Arachidonic Acids; Benzamides; Brain; Cannabinoids; Carbamates; Gastrointestinal Transit; Hyperalgesia; Indoles; Mice; Mice, Inbred C57BL; Morphine; Morpholines; Neuralgia; Nociception; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2018 |
Cannabinoid CB
Topics: Adrenergic beta-Agonists; Animals; Cannabinoid Receptor Antagonists; Drug Interactions; Heart Atria; Heart Rate; In Vitro Techniques; Indoles; Isoproterenol; Male; Myocardial Contraction; Piperidines; Pyrazoles; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Adrenergic, beta-1; Signal Transduction | 2019 |
Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks.
Topics: Animals; Arachidonic Acids; Benzamides; Biphenyl Compounds; Blood Pressure; Cannabinoids; Carbamates; Corticosterone; Dorsomedial Hypothalamic Nucleus; Endocannabinoids; Indoles; Male; Microinjections; N-Methylaspartate; Panic Disorder; Piperidines; Pyrazoles; Rats | 2019 |
Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB
Topics: Analgesics; Animals; Arachidonic Acids; Cannabinoids; Dose-Response Relationship, Drug; Drug Synergism; Indoles; Infusions, Intraventricular; Ketamine; Male; Mice; Organophosphonates; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2019 |
Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
Topics: Animals; Behavior, Animal; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Feeding Behavior; Indoles; Mice; Mice, Knockout; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Self Administration; Sucrose; Sweetening Agents | 2020 |
CB
Topics: Animals; Indoles; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Swimming; Zebrafish; Zebrafish Proteins | 2019 |
Cannabinoid system involves in the analgesic effect of protocatechuic acid.
Topics: Acetic Acid; Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxybenzoates; Indoles; Male; Mice; Pain; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid | 2019 |
Cannabinoid receptors and the proconvulsant effect of toxoplasmosis in mice.
Topics: Animals; Benzodioxoles; Cannabinoids; Disease Models, Animal; Indoles; Male; Mice; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Toxoplasma; Toxoplasmosis | 2020 |
N‑linoleyltyrosine protects PC12 cells against oxidative damage via autophagy: Possible involvement of CB1 receptor regulation.
Topics: Adenine; Animals; Arachidonic Acids; Autophagy; Cell Survival; Endocannabinoids; Hydrogen Peroxide; Indoles; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Tyrosine | 2020 |
Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Capsaicin; Disease Models, Animal; Dopaminergic Neurons; Humans; Indoles; Mice; Mice, Inbred C57BL; Neurogenic Inflammation; Neuroglia; Neuroprotection; Parkinson Disease; Piperidines; Pyrazoles; Receptor Cross-Talk; Receptors, Cannabinoid; Substantia Nigra; TRPV Cation Channels | 2020 |
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice.
Topics: Allosteric Regulation; Animals; Benzeneacetamides; Cannabinoids; Indoles; Male; Mice; Mice, Transgenic; Piperidines; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB2; Rotarod Performance Test; Seizures | 2021 |
The ω-3 endocannabinoid docosahexaenoyl ethanolamide reduces seizure susceptibility in mice by activating cannabinoid type 1 receptors.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Docosahexaenoic Acids; Fatty Acids, Omega-3; Indoles; Male; Mice; Pentylenetetrazole; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Seizures | 2021 |
Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
Topics: Animals; Arachidonic Acids; Capsaicin; Constriction; Disease Models, Animal; Endocannabinoids; Hyperalgesia; Indoles; Male; Neuralgia; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rotarod Performance Test; Spinal Cord; TRPV Cation Channels | 2021 |